UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia

Haematologica (Roma), 2024-03, Vol.109 (3), p.740

2024

Link zum Volltext

Verfügbarkeit prüfen

FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report

Cytometry. Part A, 2024-01, Vol.105 (1), p.24-35

2024

Link zum Volltext

Verfügbarkeit prüfen

Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)

Paediatric drugs, 2023-11, Vol.25 (6), p.719-728

2023

Link zum Volltext

Verfügbarkeit prüfen

Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A -Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group

Journal of clinical oncology, 2023-06, Vol.41 (16), p.2963-2974

2023

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor

Frontiers in immunology, 2022-06, Vol.13

2022

Link zum Volltext

Verfügbarkeit prüfen

Automated identification of cell populations in flow cytometry data with transformers

Computers in biology and medicine, 2022-05, Vol.144, p.105314-105314, Article 105314

2022

Link zum Volltext

Verfügbarkeit prüfen

UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia

Cancers, 2022-02, Vol.14 (4), p.898

2022

Link zum Volltext

Verfügbarkeit prüfen

Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor

Frontiers in immunology, 2022, Vol.13, p.869047-869047

2022

Link zum Volltext

Verfügbarkeit prüfen

Towards Self-explainable Transformers for Cell Classification in Flow Cytometry Data

Interpretability of Machine Intelligence in Medical Image Computing, 2022, Vol.13611, p.22-32

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

Blood, 2021-12, Vol.138 (23), p.2441-2445

2021

Link zum Volltext

Verfügbarkeit prüfen

The variable biological signature of refractory cytopenia of childhood (RCC), a retrospective EWOG-MDS study

Leukemia research, 2021-09, Vol.108, p.106652-106652, Article 106652

2021

Link zum Volltext

Verfügbarkeit prüfen

Phospho‐Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia

HemaSphere, 2020-02, Vol.4 (1), p.e312-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Flow-Cytometric Monitoring of Minimal Residual Disease in Pediatric Patients With Acute Myeloid Leukemia: Recent Advances and Future Strategies

Frontiers in pediatrics, 2019-10, Vol.7, p.412-412

2019

Link zum Volltext

Verfügbarkeit prüfen

Automated Flow Cytometric MRD Assessment in Childhood Acute B‐ Lymphoblastic Leukemia Using Supervised Machine Learning

Cytometry. Part A, 2019-09, Vol.95 (9), p.966-975

2019

Link zum Volltext

Verfügbarkeit prüfen

Flow‐cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B‐cell precursor acute lymphoblastic leukemia in trial AIEOP‐BFM‐ALL 2000

Pediatric blood & cancer, 2019-05, Vol.66 (5), p.e27590-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study

Haematologica (Roma), 2018-09, Vol.103 (9), p.1484

2018

Link zum Volltext

Verfügbarkeit prüfen

Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia: Characteristics and treatment outcome

Memo - Magazine of European medical oncology, 2018-03, Vol.11 (1), p.47-53

2018

Link zum Volltext

Verfügbarkeit prüfen

In need of special care: adolescent and young adult patients with cancer

Memo - Magazine of European medical oncology, 2018-03, Vol.11 (1), p.5-6

Dworzak, Michael N.

2018

Link zum Volltext

Verfügbarkeit prüfen

AIEOP‐BFM Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia

Cytometry. Part B, Clinical cytometry, 2018-01, Vol.94 (1), p.82-93

2018

Link zum Volltext

Verfügbarkeit prüfen

MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy

Leukemia & lymphoma, 2017-12, Vol.58 (12), p.2895-2904

2017

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups

Pediatric blood & cancer, 2017-12, Vol.64 (12), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

First experience of the AML‐Berlin‐Frankfurt‐Münster group in pediatric patients with standard‐risk acute promyelocytic leukemia treated with arsenic trioxide and all‐trans retinoid acid

Pediatric blood & cancer, 2017-08, Vol.64 (8), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

SpracheDeutsch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(84)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(89)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(68)
Humans
(55)
Child
(44)
Hematology
(42)
Adolescent
(34)
Child, Preschool
(33)
Male
(30)
Female
(28)
Biological And Medical Sciences
(26)
Medical Sciences
(25)
Infant
(23)
Flow Cytometry
(22)
Oncology
(21)
Hematologic And Hematopoietic Diseases
(18)
Treatment Outcome
(17)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Cell Biology
(14)
Prognosis
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment

Optimized Cytogenetic Risk-Group Stratification of KMT2A-Rearranged Pediatric Acute Myeloid Leukemia

Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia

FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report

Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)

Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A -Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group

Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor

Automated identification of cell populations in flow cytometry data with transformers

Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS

UMAP Based Anomaly Detection for Minimal Residual Disease Quantification within Acute Myeloid Leukemia

Case Report: Refractory Cytopenia With a Switch From a Transient Monosomy 7 to a Disease-Ameliorating del(20q) in a NHEJ1-Deficient Long-term Survivor

Towards Self-explainable Transformers for Cell Classification in Flow Cytometry Data

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

The variable biological signature of refractory cytopenia of childhood (RCC), a retrospective EWOG-MDS study

Phospho‐Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia

Flow-Cytometric Monitoring of Minimal Residual Disease in Pediatric Patients With Acute Myeloid Leukemia: Recent Advances and Future Strategies

Automated Flow Cytometric MRD Assessment in Childhood Acute B‐ Lymphoblastic Leukemia Using Supervised Machine Learning

Flow‐cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B‐cell precursor acute lymphoblastic leukemia in trial AIEOP‐BFM‐ALL 2000

Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB study

Adolescents and young adults with acute lymphoblastic leukemia and acute myeloid leukemia: Characteristics and treatment outcome

In need of special care: adolescent and young adult patients with cancer

AIEOP‐BFM Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia

MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy

Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups

First experience of the AML‐Berlin‐Frankfurt‐Münster group in pediatric patients with standard‐risk acute promyelocytic leukemia treated with arsenic trioxide and all‐trans retinoid acid

Aktive Filter

Suchergebnisse filtern